chr19-7152692-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000598216.1(INSR):n.2240G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0311 in 1,571,264 control chromosomes in the GnomAD database, including 7,858 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.043 ( 882 hom., cov: 31)
Exomes 𝑓: 0.030 ( 6976 hom. )
Consequence
INSR
ENST00000598216.1 non_coding_transcript_exon
ENST00000598216.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.403
Publications
10 publications found
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 19-7152692-C-T is Benign according to our data. Variant chr19-7152692-C-T is described in ClinVar as Benign. ClinVar VariationId is 1269775.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.472 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.2231+34G>A | intron_variant | Intron 10 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3 | c.2231+34G>A | intron_variant | Intron 10 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3 | c.2231+34G>A | intron_variant | Intron 10 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4 | c.2231+34G>A | intron_variant | Intron 10 of 20 | XP_011526291.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000598216.1 | n.2240G>A | non_coding_transcript_exon_variant | Exon 10 of 10 | 1 | |||||
| INSR | ENST00000302850.10 | c.2231+34G>A | intron_variant | Intron 10 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9 | c.2231+34G>A | intron_variant | Intron 10 of 20 | 1 | ENSP00000342838.4 |
Frequencies
GnomAD3 genomes AF: 0.0428 AC: 6499AN: 151976Hom.: 878 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
6499
AN:
151976
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0837 AC: 20858AN: 249218 AF XY: 0.0725 show subpopulations
GnomAD2 exomes
AF:
AC:
20858
AN:
249218
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0299 AC: 42399AN: 1419170Hom.: 6976 Cov.: 26 AF XY: 0.0288 AC XY: 20411AN XY: 708250 show subpopulations
GnomAD4 exome
AF:
AC:
42399
AN:
1419170
Hom.:
Cov.:
26
AF XY:
AC XY:
20411
AN XY:
708250
show subpopulations
African (AFR)
AF:
AC:
103
AN:
32612
American (AMR)
AF:
AC:
9994
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
AC:
223
AN:
25900
East Asian (EAS)
AF:
AC:
20308
AN:
39464
South Asian (SAS)
AF:
AC:
3455
AN:
85250
European-Finnish (FIN)
AF:
AC:
2984
AN:
53204
Middle Eastern (MID)
AF:
AC:
22
AN:
4184
European-Non Finnish (NFE)
AF:
AC:
2835
AN:
1075000
Other (OTH)
AF:
AC:
2475
AN:
58900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
1681
3361
5042
6722
8403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0428 AC: 6509AN: 152094Hom.: 882 Cov.: 31 AF XY: 0.0509 AC XY: 3784AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
6509
AN:
152094
Hom.:
Cov.:
31
AF XY:
AC XY:
3784
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
206
AN:
41522
American (AMR)
AF:
AC:
2551
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
15
AN:
3466
East Asian (EAS)
AF:
AC:
2498
AN:
5118
South Asian (SAS)
AF:
AC:
265
AN:
4814
European-Finnish (FIN)
AF:
AC:
638
AN:
10602
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
267
AN:
68000
Other (OTH)
AF:
AC:
68
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
231
463
694
926
1157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
758
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.